|
1
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Erez N, Truitt M, Olson P, Arron ST and
Hanahan D: Cancer-associated fibroblasts are activated in incipient
neoplasia to orchestrate tumor-promoting inflammation in an
NF-kappaB-dependent manner. Cancer Cell. 17:135–147. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olumi AF, Grossfeld GD, Hayward SW,
Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts
direct tumor progression of initiated human prostatic epithelium.
Cancer Res. 59:5002–5011. 1999.PubMed/NCBI
|
|
4
|
Yang G, Rosen DG, Zhang Z, Bast RC Jr,
Mills GB, Colacino JA, Mercado-Uribe I and Liu J: The chemokine
growth-regulated oncogene 1 (Gro-1) links RAS signaling to the
senescence of stromal fibroblasts and ovarian tumorigenesis. Proc
Natl Acad Sci USA. 103:pp. 16472–16477. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hwang RF, Moore T, Arumugam T,
Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD:
Cancer-associated stromal fibroblasts promote pancreatic tumor
progression. Cancer Res. 68:918–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu M, Peluffo G, Chen H, Gelman R, Schnitt
S and Polyak K: Role of COX-2 in epithelial-stromal cell
interactions and progression of ductal carcinoma in situ of the
breast. Proc Natl Acad Sci USA. 106:pp. 3372–3377. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Togo S, Polanska UM, Horimoto Y and Orimo
A: Carcinoma-associated fibroblasts are a promising therapeutic
target. Cancers (Basel). 5:149–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pula B, Witkiewicz W, Dziegiel P and
Podhorska-Okolow M: Significance of podoplanin expression in
cancer-associated fibroblasts: A comprehensive review. Int J Oncol.
42:1849–1857. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitano H, Kageyama S, Hewitt SM, Hayashi
R, Doki Y, Ozaki Y, Fujino S, Takikita M, Kubo H and Fukuoka J:
Podoplanin expression in cancerous stroma induces lymphangiogenesis
and predicts lymphatic spread and patient survival. Arch Pathol Lab
Med. 134:1520–1527. 2010.PubMed/NCBI
|
|
10
|
Pula B, Jethon A, Piotrowska A,
Gomulkiewicz A, Owczarek T, Calik J, Wojnar A, Witkiewicz W, Rys J,
Ugorski M, et al: Podoplanin expression by cancer-associated
fibroblasts predicts poor outcome in invasive ductal breast
carcinoma. Histopathology. 59:1249–1260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schoppmann SF, Jesch B, Riegler MF,
Maroske F, Schwameis K, Jomrich G and Birner P: Podoplanin
expressing cancer associated fibroblasts are associated with
unfavourable prognosis in adenocarcinoma of the esophagus. Clin Exp
Metastasis. 30:441–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi SY, Sung R, Lee SJ, Lee TG, Kim N,
Yoon SM, Lee EJ, Chae HB, Youn SJ and Park SM: Podoplanin, α-smooth
muscle actin or S100A4 expressing cancer-associated fibroblasts are
associated with different prognosis in colorectal cancers. J Korean
Med Sci. 28:1293–1301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamanashi T, Nakanishi Y, Fujii G,
Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M and Hirohashi S:
Podoplanin expression identified in stromal fibroblasts as a
favorable prognostic marker in patients with colorectal carcinoma.
Oncology. 77:53–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
International Union Against Cancer, . TNM
Classification of Malignant TumoursSobin LH, Gospodarowicz MK and
Wittekind CH: 7th. Wiley-Blackwell; New York, NY: 2009
|
|
15
|
Japanese Society for Cancer of the Colon
and Rectum: Japanese Classification of Colorectal Carcinoma.
Kanehara & Co., Ltd.; Tokyo: 2013
|
|
16
|
Takatsuna M, Morohashi S, Yoshizawa T,
Hirai H, Haga T, Ota R, Saito K, Wu Y, Seino H, Aoyagi Y, et al:
Myofibroblast distribution is associated with invasive growth types
of colorectal cancer. Oncol Rep. 36:3154–3160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takatsuna M, Morohashi S, Yoshizawa T,
Hirai H, Haga T, Ota R, Wu Y, Morohashi H, Hakamada K, Terai S and
Kijima H: Myofibroblasts of the muscle layer stimulate the
malignant potential of colorectal cancer. Oncol Rep. 36:1251–1257.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kitadai Y, Sasaki T, Kuwai T, Nakamura T,
Bucana CD, Hamilton SR and Fidler IJ: Expression of activated
platelet-derived growth factor receptor in stromal cells of human
colon carcinomas is associated with metastatic potential. Int J
Cancer. 119:2567–2574. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zou X, Feng B, Dong T, Yan G, Tan B, Shen
H, Huang A, Zhang X, Zhang M, Yang P, et al: Up-regulation of type
I collagen during tumorigenesis of colorectal cancer revealed by
quantitative proteomic analysis. J Proteomics. 94:473–485. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kitadai Y, Sasaki T, Kuwai T, Nakamura T,
Bucana CD and Fidler IJ: Targeting the expression of
platelet-derived growth factor receptor by reactive stroma inhibits
growth and metastasis of human colon carcinoma. Am J Pathol.
169:2054–2065. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sumida T, Kitadai Y, Shinagawa K, Tanaka
M, Kodama M, Ohnishi M, Ohara E, Tanaka S, Yasui W and Chayama K:
Anti-stromal therapy with imatinib inhibits growth and metastasis
of gastric carcinoma in an orthotopic nude mouse model. Int J
Cancer. 128:2050–2062. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kono T, Shimoda M, Takahashi M, Matsumoto
K, Yoshimoto T, Mizutani M, Tabata C, Okoshi K, Wada H and Kubo H:
Immunohistochemical detection of the lymphatic marker podoplanin in
diverse types of human cancer cells using a novel antibody. Int J
Oncol. 31:501–508. 2007.PubMed/NCBI
|
|
23
|
Wicki A, Lehembre F, Wick N, Hantusch B,
Kerjaschki D and Christofori G: Tumor invasion in the absence of
epithelial-mesenchymal transition: Podoplanin-mediated remodeling
of the actin cytoskeleton. Cancer Cell. 9:261–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sugimoto Y, Watanabe M, Oh-hara T, Sato S,
Isoe T and Tsuruo T: Suppression of experimental lung colonization
of a metastatic variant of murine colon adenocarcinoma 26 by a
monoclonal antibody 8F11 inhibiting tumor cell-induced platelet
aggregation. Cancer Res. 51:921–925. 1991.PubMed/NCBI
|
|
25
|
Watanabe M, Okochi E, Sugimoto Y and
Tsuruo T: Identification of a platelet-aggregating factor of murine
colon adenocarcinoma 26: Mr 44,000 membrane protein as determined
by monoclonal antibodies. Cancer Res. 48:6411–6416. 1988.PubMed/NCBI
|
